0.7775
Adicet Bio Inc Stock (ACET) Latest News
Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9% - Defense World
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com
Adicet Bio (ACET) Expected to Announce Earnings on Tuesday - Defense World
Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio - TipRanks
Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World
Adicet Bio Advances Clinical Trials and Financial Stability - TipRanks
H.C. Wainwright maintains Neutral on Adicet Bio stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Neutral on Adicet Bio stock - Investing.com India
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes - TipRanks
Adicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data - TipRanks
Adicet Bio Inc Files For Mixed Shelf Of Up To $250 Million -March 06, 2025 at 04:59 pm EST - Marketscreener.com
Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Lelezard
Adicet Bio, Inc Q4 Loss Decreases - Nasdaq
Adicet Bio reports Q4 EPS (32c), consensus (35c) - TipRanks
Can Adicet Bio's $176M War Chest and Fast Track Status Transform Autoimmune Treatment? - StockTitan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Average Target Price from Analysts - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting - Business Wire
Adicet Bio's (ACET) "Neutral" Rating Reaffirmed at HC Wainwright - MarketBeat
Adicet Bio shares rise on FDA Fast Track Designation for ADI-001 - Investing.com
FDA fast tracks Adicet Bio's autoimmune therapy By Investing.com - Investing.com South Africa
FDA fast tracks Adicet Bio’s autoimmune therapy - Investing.com
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc) - Lelezard
FDA fast tracks Adicet Bio’s autoimmune therapy By Investing.com - Investing.com UK
Adicet's Systemic Sclerosis Therapy Earns Critical FDA Fast Track StatusWhat This Means for Patients - StockTitan
Adicet Bio (NASDAQ:ACET) versus Corvus Pharmaceuticals (NASDAQ:CRVS) Head to Head Analysis - Defense World
Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa
Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com
Healthy Upside Potential: Adicet Bio Inc (ACET) - SETE News
Adicet Bio Inc [ACET] Insider Activity: An Update for Investors - Knox Daily
Investor Alert: What’s Really Going On At Adicet Bio Inc (NASDAQ: ACET) - Stocks Register
Adicet Bio (NASDAQ:ACET) Earns Market Perform Rating from JMP Securities - MarketBeat
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.50 - MarketBeat
Adicet Bio reports progress in clinical trial enrollments - MSN
HC Wainwright Reaffirms Neutral Rating for Adicet Bio (NASDAQ:ACET) - MarketBeat
Adicet Bio (NASDAQ:ACET) Earns “Market Perform” Rating from JMP Securities - Defense World
Top investors say Adicet Bio Inc (ACET) ticks everything they need - SETE News
Major Win – FDA Grants Fast Track Designation to Adicet Bio’s ADI-001 for Lupus Disease - geneonline
Adicet Bio Inc [NASDAQ: ACET] Sees Increase in Stock Value - Knox Daily
Is Adicet Bio (NASDAQ:ACET) In A Good Position To Invest In Growth? - Simply Wall St
Adicet Bio reports progress in clinical trial enrollments By Investing.com - Investing.com Australia
Adicet Bio Inc (ACET) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Adicet Bio Inc (ACET) Stock Price and Analyst Predictions - The News Heater
What is ACET’s price-to-sales ratio telling us about the company’s value? - US Post News
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement - Marketscreener.com
Revolutionary Lupus Treatment Gets FDA Fast-Track: Adicet's ADI-001 Could Transform Patient Care - StockTitan
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):